FN2 Earnings Intelligence
Universal Health Services, Inc. financials (quarterly)
Universal Health Services, Inc. (UHS) Key Stats (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 est. | 9/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $106.1 | $126.8 | $137.6 | $112.9 | $119 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $3,963 | $4,099.7 | $4,283.8 | $4,495.2 | $4,495.2 | $4,578.9 | $4,720.4 |
| % Growth | - | - | - | - | - | 6.9% | 5.0% |
| Gross Profit | - | - | - | - | - | - | - |
| % Margin | - | - | - | - | - | - | - |
| EBITDA | $533.7 | $603.2 | $652.3 | $676.7 | $658.3 | - | - |
| % Margin | 13.5% | 14.7% | 15.2% | 15.1% | 14.6% | - | - |
| Net Income | $258.7 | $316.7 | $353.2 | $373 | $348.7 | - | - |
| % Margin | 6.5% | 7.7% | 8.2% | 8.3% | 7.8% | - | - |
| Diluted EPS | $3.80 | $4.80 | $5.43 | $5.86 | $5.65 | $5.94 | $5.40 |
| % Growth | - | - | - | - | - | 9.4% | -7.9% |
| Operating Cash Flow | - | $360 | - | - | $401.6 | - | - |
| CapEx | - | $239 | - | - | $217.2 | - | - |
| Free Cash Flow | - | $121 | - | - | $184.5 | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 est. | 9/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $3,963 | $4,099.7 | $4,283.8 | $4,495.2 | $4,495.2 | $4,578.9 | $4,720.4 |
| Gross Profit | - | - | - | - | - | - | - |
| EBITDA | $533.7 | $603.2 | $652.3 | $676.7 | $658.3 | - | - |
| Net Income | $258.7 | $316.7 | $353.2 | $373 | $348.7 | - | - |
| Diluted EPS | $3.80 | $4.80 | $5.43 | $5.86 | $5.65 | $5.94 | $5.40 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $106.1 | $126.8 | $137.6 | $112.9 | $119 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | $4,618.1 | $4,609.3 | $4,542 | $3,950.9 | $3,952.1 |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | $360 | - | - | $401.6 |
| Capital Expenditure | - | $239 | - | - | $217.2 |
| Free Cash Flow | - | $121 | - | - | $184.5 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | - | - | - | - | - |
| EBITDA Margin | 13.5% | 14.7% | 15.2% | 15.1% | 14.6% |
| Net Margin | 6.5% | 7.7% | 8.2% | 8.3% | 7.8% |
| FCF Margin | - | 3.0% | - | - | 4.1% |
| Diluted EPS Growth | - | - | - | - | - |